Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|December 27, 2021
MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and PotentialBehnaz Lahooti, Sagun Poudel, Constantinos M Mikelis, et al.
Clinical Immunology (Orlando, Fla.)|April 6, 2015
Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseasesThanh-Huyen Tran, George Mattheolabakis, Hibah Aldawsari, et al.
Nanomedicine (London, England)|November 19, 2019
miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?A K M Nawshad Hossian, Gerardo G Mackenzie, George Mattheolabakis
Pharmaceutics|August 10, 2021
Oral Delivery of Nucleic Acids with Passive and Active Targeting to the Intestinal Tissue Using Polymer-Based NanocarriersSagun Poudel, Prabhat R Napit, Karen P Briski, et al.
Oncology Reports|March 2, 2021
Combination of miR‑143 and miR‑506 reduces lung and pancreatic cancer cell growth through the downregulation of cyclin‑dependent kinasesA K M Nawshad Hossian, Gerardo G Mackenzie, George Mattheolabakis
International Journal of Pharmaceutics: X|September 23, 2024
Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA deliveryMd Anamul Haque, Archana Shrestha, Constantinos M Mikelis, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 22, 2008
In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticlesGeorge Mattheolabakis, Era Taoufik, Sylva Haralambous, et al.
Pageof 5